Back

Moderate and vigorous physical activity levels are associated with circulating CD34+ progenitor cells which are predictive of all-cause and cardiovascular mortality

17 April 2021 (08:57 - 09:05)
Organised by:
Congress Presentation Part of: Young Investigators Award Sports Cardiology and Exercise Exercise EAPC Premium Access ESC Preventive Cardiology 2021

About the speaker

Photo
Assistant Professor Mark Ross

Edinburgh Napier University, Edinburgh (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Symptoms, ecg-changes and family history of cardiac disease precedes sudden cardiac death in hypertrophic cardiomyopathy - A nationwide study among the young in Sweden 2000-2010
Doctor E. Borjesson (Kungalv, SE)
Abstract Slides Video
Presentation thumbnail
Exercise intensity is associated with progression of coronary artery calcification in middle-aged and older athletes: findings from the MARC-2 study
Doctor V. Aengevaeren (Nijmegen, NL)
Abstract Slides Video
Presentation thumbnail
Six-month outcomes of a high intensity exercise programme in young patients with hypertrophic cardiomyopathy: The SAFE-HCM trial
Doctor J. Basu (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Clinical management of young competitive athletes with premature ventricular beats: a prospective cohort study
Doctor L. Cavigli (Siena, IT)
Abstract Slides Video
Presentation thumbnail
Analysis of exercise capacity, quality of life and leisure sports in patients with a Fontan circulation
Mr A. Niemann (Kiel, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigators Award Sports Cardiology and Exercise
Video

The Event

Event poster

ESC Preventive Cardiology 2021

17 April 2021 08:57 CET
You may be interested in
thumbnail
Congress Presentation
Secondary prevention and rehabilitation
thumbnail
Congress Presentation
Which exercise is possible with hypertensive heart disease?
thumbnail
Congress Presentation
Evidence-based lifestyle interventions for cardiovascular prevention in obesity

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources